June 26, 2018

Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock

Aerpio Pharmaceuticals (OTCQB:ARPO) announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO”...
June 25, 2018

Aerpio and Gossamer Bio Announce License Agreement

The agreement could bring sales milestones of Aerpio up to US$400 million, including US$20 million as an upfront payment, potential...
June 25, 2018

Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924

Aerpio Pharmaceuticals (OTCQB:ARPO), announced an exclusive global license agreement with a wholly owned subsidiary of Gossamer Bio, GB004, for the...